I. Principle and Intended Use
1.1 Principle
DNA pull-down is an in vitro method for detecting and enriching DNA–protein interactions. The workflow is as follows:
(1) A DNA fragment containing the cis-regulatory element of interest (e.g., promoter, enhancer, silencer, or other regulatory sequence) is biotin-labeled and used as the “bait” probe.
(2) The biotin-labeled DNA is immobilized on a solid support (commonly magnetic beads) coated with streptavidin, forming a DNA–bead complex.
(3) The DNA–bead complex is incubated with a protein sample (nuclear extract, total protein lysate, or a mixture of purified proteins), allowing proteins that specifically bind the DNA sequence to associate with the bait.
(4) Magnetic separation and stepwise washing are used to remove nonspecifically bound proteins. Proteins eluted from the beads represent the interacting protein pool for the DNA fragment.
(5) Pulled-down proteins can be analyzed by Western blot (WB) or identified by mass spectrometry (MS).
This method relies on the high-affinity biotin–streptavidin interaction, enabling stable immobilization of the DNA probe and efficient enrichment of DNA–protein complexes.
1.2 Major applications
(1) Mechanistic studies of gene expression regulation
Identify transcription factors and co-regulatory complexes binding to promoters/enhancers/silencers to elucidate molecular bases of transcriptional activation or repression.
(2) Construction of DNA–protein interaction maps
Cross-validate and complement in vivo data such as ChIP-qPCR/ChIP-seq to confirm binding protein profiles at specific genomic regions.
(3) Functional evaluation of disease-associated variants
Determine whether non-coding variants alter protein–DNA binding and thereby perturb gene expression.
(4) Drug target discovery and validation
Screen small molecules or other interventions that disrupt key protein–DNA interactions, supporting target identification and validation.
II. Samples and Reagent Preparation
2.1 Sample types and recommended input
(1) Cell samples
① Cell number: ~3 × 10⁷ cells, or ~3 dishes of 10 cm culture plates at 80%–90% confluence.
② Collect cells by centrifugation; pellet volume should be ~80–100 μL.
(2) Animal tissue samples
At least 0.5 g fresh tissue; minimize the time between excision and processing.
(3) Plant tissue samples
At least 1 g fresh young tissue; avoid aged or highly lignified tissue.
(4) Template plasmid (for PCR-based DNA probe preparation)
At least 20 μL total volume; concentration ≥ 20 ng/μL; ship and store cold.
(5) Antibody (for WB detection only)
Western blot–grade, target-specific antibody ≥ 10 μL.
(6) Notes
① For drug-treated cells/tissues, wash twice with pre-chilled PBS before collection to reduce residual compound effects on protein activity and binding.
② Perform the workflow on ice or at 4°C whenever possible to minimize protein degradation.
2.2 Protein sample preparation
(1) Sample pre-processing
① Cells: wash with PBS and collect cell pellets.
② Animal tissues: mince and wash thoroughly with pre-chilled PBS, then homogenize mechanically.
③ Plant tissues: grind into a fine powder in liquid nitrogen and immediately add lysis buffer.
(2) Lysis and inhibition
① Select an appropriate cold lysis buffer (e.g., nuclear extraction buffer, IP lysis buffer, or plant protein lysis buffer) and supplement with suitable protease and phosphatase inhibitors.
② Incubate on ice throughout lysis, gently inverting periodically.
(3) Sonication
① Sonicate in an ice bath; typical settings: ~20% power, 3 s ON / 3 s OFF.
② Suggested duration: animal tissue ~5 min; cells ~2 min; plant tissue ~10 min.
③ Avoid excessive foaming to reduce mechanical damage and protein degradation.
(4) Clarification and storage
① Centrifuge at 12,000 rpm for 10 min at 4°C; collect the supernatant as total protein.
② Measure protein concentration if needed (BCA/Bradford, etc.).
③ Store at 4°C short-term; store at −20°C or −80°C long-term. Avoid repeated freeze–thaw cycles; aliquot when appropriate.
2.3 DNA probe design and preparation
(1) When the target region is defined and short (tens to hundreds of bp)
① Chemically synthesize double-stranded DNA with a 5′ biotin label and use it directly as the pull-down probe.
(2) When the target region is unclear or a larger upstream region is required
① Design primers to cover an upstream region starting ~2000 bp upstream of the transcription start site (TSS).
② Biotin-label one primer and amplify an ~2 kb biotin-labeled DNA fragment by PCR.
③ Confirm a single specific band by agarose gel electrophoresis, then excise and purify the PCR product.
④ Quantify and use as the DNA pull-down probe.
(3) Control probes
① Use an equal-length biotin-labeled DNA lacking the binding site (or containing binding-site mutations / randomized sequence) as a negative control, or include a beads-only control (no DNA).
② Alternatively, use a biotin-labeled random-sequence DNA without specific binding sites as a nonspecific-binding control.
III. Experimental Procedure
3.1 Magnetic bead pre-treatment
(1) Resuspend beads
Remove streptavidin magnetic beads from 4°C and gently invert to fully resuspend.
(2) Aliquot
Dispense ~30 μL beads into two 1.5 mL microcentrifuge tubes as:
① Experimental group (biotin-labeled DNA).
② Control group (biotin-labeled nonspecific DNA / binding-site mutant probe; or beads-only control (no DNA)).
(3) Wash
① Place tubes on a magnetic rack for ~1 min until beads are fully captured.
② Discard supernatant.
③ Add ~500 μL pre-chilled nucleic-acid binding/equilibration buffer and gently resuspend beads.
④ Return to the magnetic rack for 1 min; discard supernatant.
⑤ Repeat once if needed.
3.2 DNA immobilization on beads
(1) Add probes
① Experimental group: add ~1–5 μg biotin-labeled DNA probe (for short oligonucleotide probes, optimize at ~10–100 pmol; for long fragments, do not calculate dosage as 100–300 pmol).
② Control group: add an equal amount of biotin-labeled nonspecific DNA (or binding-site mutant probe), or include a beads-only control (no DNA).
③ Bring each tube to ~500 μL total volume with nucleic-acid buffer.
(2) Incubation
① Incubate at room temperature for ~2 h with gentle agitation or static incubation to allow complete biotin–streptavidin binding.
② After incubation, place tubes on a magnetic rack to capture beads. Keep the supernatant if needed (for assessing binding efficiency).
(3) Wash
① Add ~1 mL nucleic-acid buffer to resuspend beads.
② Magnetically separate for 1 min; discard supernatant.
③ Wash 3 times in total; after the final wash, remove residual supernatant as completely as possible.
3.3 DNA–protein binding
(1) Add protein sample
① Add 300–2000 μg total protein per tube (adjust based on protein abundance and experimental goal).
② Add protease inhibitors such as 1 mM PMSF.
③ Bring to 1 mL total volume with protein incubation buffer.
(2) Input control
Aliquot ~100 μL protein lysate as the Input sample. Add loading buffer and store for later comparison.
(3) Incubation conditions
① Incubate at 4°C with rotation or gentle agitation overnight (typically 12–16 h).
② After incubation, place tubes on a magnetic rack and retain the supernatant if needed (to assess depletion).
(4) Wash
① Add ~1 mL pre-chilled protein incubation buffer and gently resuspend beads.
② Magnetically separate for 1 min; discard supernatant.
③ Wash 5 times to remove nonspecific binders.
④ After washing, optionally equilibrate briefly at room temperature for ~30 min before elution to facilitate partial complex dissociation.
3.4 Elution and sample preparation
(1) Denaturing elution (commonly for WB)
① Add ~100 μL elution buffer (e.g., SDS-containing loading buffer or a compatible system).
② Heat at 95–100°C for 8–10 min in a water bath or dry block to release proteins from DNA–beads.
③ Magnetically separate or briefly centrifuge and collect the supernatant as the pull-down eluate.
④ Adjust to 1× SDS-PAGE loading buffer if needed (skip if already used).
⑤ Boil again for 3–5 min and store at −20°C.
(2) Input processing
① Mix Input sample with an equal volume of 2× loading buffer.
② Boil for 3–5 min and store at −20°C.
(3) Additional handling for MS analysis
① If LC-MS/MS identification is planned, reserve ~1/4 of the bead suspension before the final wash and transfer to a new tube.
② Wash 3 times with PBS to remove interfering components.
③ Discard supernatant and store beads directly at −20°C; proceed with MS sample preparation workflows as required.
3.5 Detection and interpretation
(1) Western blot (for known candidate proteins)
① Separate Input, experimental pull-down, and control pull-down samples by SDS-PAGE.
② Transfer and probe using primary antibody against the candidate protein.
③ A specific band in the experimental pull-down but not in the control indicates sequence-specific binding.
④ If Input shows a band but experimental pull-down does not, evaluate protein abundance, antibody performance, and pull-down conditions.
(2) Silver staining and MS (for discovery of unknown interactors)
① Use silver staining for high-sensitivity visualization and to assess band complexity.
② If expected band size is known, excise the band for MS.
③ Alternatively, analyze the full sample by LC-MS/MS and filter nonspecific background using the control dataset.
IV. Key Points for Result Interpretation
4.1 Specificity assessment
(1) Clear band in experimental group but not in control
Indicates specific binding proteins for the DNA probe.
(2) Similar bands in experimental and control groups
Suggests strong nonspecific binding; optimize conditions (add competitor DNA, increase wash ionic strength, etc.).
(3) No target band in Input/experimental/control
First confirm whether the target protein is present in the sample (by conventional WB). If basal expression is extremely low, consider overexpression or an alternative sample source.
4.2 Integration with in vivo data
DNA pull-down provides in vitro binding evidence and is commonly supported by:
(1) ChIP-qPCR/ChIP-seq;
(2) reporter assays;
(3) phenotypic analysis after gene knockdown/knockout;
to strengthen biological conclusions.
V. Common Issues and Troubleshooting
5.1 High nonspecific background
(1) Optimize DNA probe design
① Avoid repetitive sequences and regions with extreme AT/GC content prone to nonspecific binding.
② Shorten probe length to focus on the functional core element.
(2) Add competitor DNA
① Add nonspecific competitor DNA to the binding reaction (e.g., Poly(dI·dC) or salmon sperm DNA) to reduce binding to nonspecific sequences.
(3) Optimize washing conditions
① Increase ionic strength of wash buffer or add a small amount of non-ionic detergent.
② Increase wash number or extend wash duration.
5.2 Weak or missing binding signal for the target protein
(1) Preserve protein activity
① Use freshly prepared nuclear extract/total protein; avoid repeated freeze–thaw cycles.
② Keep samples cold and include protease/phosphatase inhibitors throughout.
(2) Optimize incubation conditions
① Use overnight incubation at 4°C with rotation to approach binding equilibrium.
② For high-affinity interactions, test shortening to 1–2 h at room temperature.
(3) Increase probe or protein input
① Ensure probe is in excess relative to the target protein to maximize capture.
② Increase protein input within limits that do not cause significant degradation.
5.3 Weak WB signal or insufficient detection sensitivity
(1) Concentrate samples
① Use acetone precipitation or TCA precipitation on the eluate to concentrate proteins and reduce loading volume.
(2) Load beads directly
① In some cases, boil the bead–protein complex directly in 2× loading buffer and load the entire mixture to minimize elution losses.
(3) Improve detection sensitivity
① Use high-sensitivity chemiluminescent substrates or fluorescence-based detection systems.
② Ensure primary/secondary antibodies have good specificity and appropriate dilution.
5.4 Quantitative MS strategy selection
(1) Identification only (qualitative)
Use non-quantitative LC-MS/MS and prioritize proteins unique to or strongly enriched in the experimental group.
(2) Comparisons across conditions/treatments
For example, comparing interactomes between empty control and target overexpression conditions, use quantitative proteomics (label-based or label-free) for more reliable differential-interactor calling.
VI. Safety Notes
(1) Samples may contain potential biohazards. Wear standard laboratory PPE (gloves, lab coat, safety glasses) and follow biosafety regulations.
(2) Waste containing proteins, DNA, SDS, etc. should be collected separately and disposed of according to institutional hazardous waste procedures.
(3) When using sonicators and high-temperature baths/heat blocks, follow equipment safety practices and take precautions against burns, noise exposure, and instrument-related hazards.
Aladdin: https://www.aladdinsci.com/